Vasodilator effect of human urotensin-II on human pulmonary and resistance arteries

被引：0

作者：

Stirrat, A

Douglas, A

Kirk, A

Berry, C

Richardson, M

MacLean, MR

机构：

[1] Univ Glasgow, IBLS, Div Neurosci & Biomed Syst, Glasgow G12 8QQ, Lanark, Scotland

[2] Glasgow Western Infirm, Dept Cardiovasc Surg, Glasgow, Lanark, Scotland

[3] Univ Glasgow, Western Infirm, Dept Surg, Glasgow G11 6NT, Lanark, Scotland

来源：

BRITISH JOURNAL OF PHARMACOLOGY | 2000年 / 131卷

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

88P

引用

页码：U50 / U50

页数：1

共 50 条

[41] Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14
Ames, RS
Sarau, HM
Chambers, JK
Willette, RN
Alyar, NV
Romanic, AM
Louden, CS
Foley, JJ
Sauermelch, CF
Coatney, RW
Ao, ZH
Disa, J
Holmes, SD
Stadel, JM
Martin, JD
Liu, WS
Glover, GI
Wilson, S
McNulty, DE
Ellis, CE
Elshourbagy, NA
Shabon, U
Trill, JJ
Hay, DWP
Ohlstein, EH
Bergsma, DJ
Douglas, SA
NATURE, 1999, 401 (6750) : 282 - 286
[42] Human urotensin-II as a novel cardiovascular target: 'heart' of the matter or simply a fishy 'tail'?
Douglas, SA
CURRENT OPINION IN PHARMACOLOGY, 2003, 3 (02) : 159 - 167
[43] Immunocytochemical localization of the urotensin-II receptor, UT, to rat and human tissues: Relevance to function
Maguire, Janet J.
Kuc, Rhoda E.
Kleinz, Matthias J.
Davenport, Anthony P.
PEPTIDES, 2008, 29 (05) : 735 - 742
[44] State-dependent calcium mobilization by urotensin-II in cultured human endothelial cells
Brailoiu, Eugen
Jiang, Xiaohua
Brailoiu, G. Cristina
Yang, Jun
Chang, Jaw Kang
Wang, Hong
Dun, Nae J.
PEPTIDES, 2008, 29 (05) : 721 - 726
[45] Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14
Robert S. Ames
Henry M. Sarau
Johathan K. Chambers
Robert N. Willette
Nambi V. Aiyar
Anne M. Romanic
Calvert S. Louden
James J. Foley
Charles F. Sauermelch
Robert W. Coatney
Zhaohui Ao
Jyoti Disa
Stephen D. Holmes
Jeffrey M. Stadel
John D. Martin
Wu-Schyong Liu
George I. Glover
Shelagh Wilson
Dean E. McNulty
Catherine E. Ellis
Nabil A. Elshourbagy
Usman Shabon
John J. Trill
Douglas W. P. Hay
Eliot H. Ohlstein
Derk J. Bergsma
Stephen A. Douglas
Nature, 1999, 401 : 282 - 286
[46] Vascular reactivity to urotensin-II in hypertensive rats associated with insulin resistance
Ziberna, L.
Kogoj, P.
Drevensek, G.
Cosenzi, A.
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 83 - 83
[47] Pharmacological characterization of a novel human G-protein-coupled receptor with specificity for the vasoactive peptide human urotensin-II
Douglas, SA
Disa, J
Naselsky, D
Romanic, A
Louden, C
Ao, ZH
Foley, JJ
Elshourbagy, NA
Sarau, HM
Ames, RS
Ohlstein, EH
Willette, RN
CIRCULATION, 1999, 100 (18) : 6 - 6
[48] Potent and selective small-molecule human urotensin-II antagonists with improved pharmacokinetic profiles
McAtee, John J.
Dodson, Jason W.
Dowdell, Sarah E.
Erhard, Karl
Girard, Gerald R.
Goodman, Krista B.
Hil, Mark A.
Jin, Jian
Sehon, Clark A.
Sha, Deyou
Shi, Dongchuan
Wang, Feng
Wang, Gren Z.
Wang, Ning
Wang, Yonghui
Viet, Andrew Q.
Yuan, Catherine C. K.
Zhang, Daohua
Aiyar, Nambi V.
Behm, David J.
Carballo, Luz H.
Evans, Christopher A.
Fries, Harvey E.
Nagilla, Rakesh
Roethke, Theresa J.
Xu, Xiaoping
Douglas, Stephen A.
Neeb, Michael J.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (13) : 3716 - 3719
[49] Human urotensin-II is a potent vasoactive peptide: Pharmacological characterization in the rat, mouse, dog and primate
Douglas, SA
Ashton, DJ
Sauermelch, CF
Coatney, RW
Ohlstein, DH
Ruffolo, MR
Ohlstein, EH
Aiyar, NV
Willette, RN
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 36 : S163 - S166
[50] Pro-angiogenic activity of Urotensin-II on different human vascular endothelial cell populations
Albertin, Giovanna
Guidolin, Diego
Sorato, Elisa
Spinazzi, Raffaella
Mascarin, Alessandra
Oselladore, Barbara
Montopoli, Monica
Antonello, Michele
Ribatti, Domenico
REGULATORY PEPTIDES, 2009, 157 (1-3) : 64 - 71

← 1 2 3 4 5 →